NCT06003166View on ClinicalTrials.gov

4-AP Peripheral Nerve Crossover Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 21, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

July 31, 2028

Conditions
Peripheral Nerve InjuryCrush Injury
Interventions
DRUG

4-Aminopyridine

Study drug will be a one time, 10mg dose of 4-aminopyridine

OTHER

Placebo

Matched placebo

Trial Locations (1)

85724

RECRUITING

Banner University Medical Center, Tucson

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Arizona

OTHER